At Semmelweis University, Budapest, Hungary, heterologously expressed disease-causing variants of the human LADH are expressed and structure-function analyses are carried out in order to establish structure-based drug design.
There is on-going research at the Hebrew University, Jerusalem, Israel, aiming at improving enzyme replacement therapy which was already successfully used in patient fibroblasts and animal models.
DLD